Literature DB >> 3021905

Sexual dimorphism in the response of the GABAergic system to estrogen administration.

J Perez, I Zucchi, A Maggi.   

Abstract

Administration of estradiol benzoate to gonadectomized female rats results in up-regulation of CNS gamma-aminobutyric acid (GABA) receptors. The increase of [3H]muscimol binding activity is observed in six of the seven brain areas examined. The same treatment, performed in castrated male or androgenized female rats, induced an increase of [3H]muscimol binding only in the striatum. Evidence is provided suggesting that the dimorphic sensitivity of GABA receptor is not correlated with the difference in spontaneous motor activity reported between male and female rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021905     DOI: 10.1111/j.1471-4159.1986.tb13091.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Sex differences in GABAA receptor binding in rat brain measured by an improved in vitro binding assay.

Authors:  M Jüptner; C Hiemke
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 2.  Steroid and barbiturate modulation of the GABAa receptor. Possible mechanisms.

Authors:  M Schumacher; B S McEwen
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

3.  Delayed but not immediate effects of estrogen curtail gamma-aminobutyric acid-mediated feeding responses elicited from the nucleus accumbens shell.

Authors:  Julio C Diaz; Kate Dunaway; Elizabeth Sheil; Ken Sadeghian; Anthony Auger; Brian A Baldo
Journal:  Behav Neurosci       Date:  2022-04-07       Impact factor: 2.154

4.  Estradiol and testosterone modulate the anesthetic action of the GABA-A agonist THIP, but not of the neurosteroid 3alpha,5beta-pregnanolone in the rat.

Authors:  Oscar González-Flores; Norma Sánchez; Marcos García-Juárez; Francisco Javier Lima-Hernández; Gabriela González-Mariscal; Carlos Beyer
Journal:  Psychopharmacology (Berl)       Date:  2003-12-17       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.